BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26663671)

  • 1. Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial.
    Fisher RS; Afra P; Macken M; Minecan DN; Bagić A; Benbadis SR; Helmers SL; Sinha SR; Slater J; Treiman D; Begnaud J; Raman P; Najimipour B
    Neuromodulation; 2016 Feb; 19(2):188-95. PubMed ID: 26663671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation.
    Boon P; Vonck K; van Rijckevorsel K; El Tahry R; Elger CE; Mullatti N; Schulze-Bonhage A; Wagner L; Diehl B; Hamer H; Reuber M; Kostov H; Legros B; Noachtar S; Weber YG; Coenen VA; Rooijakkers H; Schijns OE; Selway R; Van Roost D; Eggleston KS; Van Grunderbeek W; Jayewardene AK; McGuire RM
    Seizure; 2015 Nov; 32():52-61. PubMed ID: 26552564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus nerve stimulation with tachycardia detection provides additional seizure reduction compared to traditional vagus nerve stimulation.
    Datta P; Galla KM; Sajja K; Wichman C; Wang H; Madhavan D
    Epilepsy Behav; 2020 Oct; 111():107280. PubMed ID: 32759064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
    Schneider UC; Bohlmann K; Vajkoczy P; Straub HB
    Acta Neurochir (Wien); 2015 Apr; 157(4):721-8. PubMed ID: 25673257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure improvement following vagus nerve stimulator (VNS) battery change with cardiac-based seizure detection automatic stimulation (AutoStim): early experience in a regional paediatric unit.
    Lo WB; Chevill B; Philip S; Agrawal S; Walsh AR
    Childs Nerv Syst; 2021 Apr; 37(4):1237-1241. PubMed ID: 33174154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of microburst VNS therapy in drug-resistant focal and generalized epilepsy.
    Drees C; Afra P; Verner R; Kaye L; Keith A; Jiang M; Szaflarski JP; Nichol K;
    Brain Stimul; 2024; 17(2):382-391. PubMed ID: 38499287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
    Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
    Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of VNS therapy with AspireSR
    Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
    Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial.
    Verrier RL; Nearing BD; Olin B; Boon P; Schachter SC
    Epilepsy Behav; 2016 Sep; 62():85-9. PubMed ID: 27450311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
    Kawaji H; Yamamoto T; Fujimoto A; Uchida D; Ichikawa N; Yamazoe T; Okanishi T; Sato K; Nishimura M; Tanaka T; Namba H
    Neurosci Lett; 2020 Jan; 716():134636. PubMed ID: 31751671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early experiences with tachycardia-triggered vagus nerve stimulation using the AspireSR stimulator.
    El Tahry R; Hirsch M; Van Rijckevorsel K; Santos SF; de Tourtchaninoff M; Rooijakkers H; Coenen V; Schulze-Bonhage A
    Epileptic Disord; 2016 Jun; 18(2):155-62. PubMed ID: 27248796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the correlation between short-term effectiveness of VNS Therapy in reducing the severity of seizures and long-term responsiveness.
    Ravan M
    Epilepsy Res; 2017 Jul; 133():46-53. PubMed ID: 28414968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autostimulation in Vagus Nerve Stimulator Treatment: Modulating Neuromodulation.
    Kulju T; Haapasalo J; Rainesalo S; Lehtimäki K; Peltola J
    Neuromodulation; 2019 Jul; 22(5):630-637. PubMed ID: 30549376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating vagus nerve stimulation treatment with heart rate monitoring in pediatric patients with intractable epilepsy.
    Santhumayor B; Karkare S; Kothare S; Rodgers S
    Childs Nerv Syst; 2022 Mar; 38(3):547-556. PubMed ID: 34837500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
    Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
    Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between duty cycle, tachycardia threshold and autostimulation delivery in cardio-responsive vagus nerve stimulation.
    Guzner A; Macken M
    Epilepsy Behav; 2021 Mar; 116():107728. PubMed ID: 33486238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial.
    Ryvlin P; Gilliam FG; Nguyen DK; Colicchio G; Iudice A; Tinuper P; Zamponi N; Aguglia U; Wagner L; Minotti L; Stefan H; Boon P; Sadler M; Benna P; Raman P; Perucca E
    Epilepsia; 2014 Jun; 55(6):893-900. PubMed ID: 24754318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
    Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
    Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-based vagus nerve stimulation reduced seizure duration in a patient with refractory epilepsy.
    Hampel KG; Vatter H; Elger CE; Surges R
    Seizure; 2015 Mar; 26():81-5. PubMed ID: 25799907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy.
    Suller Marti A; Mirsattari SM; MacDougall K; Steven DA; Parrent A; de Ribaupierre S; Andrade A; Diosy D; McLachlan RS; Burneo JG
    Epilepsy Behav; 2020 Oct; 111():107253. PubMed ID: 32615417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.